Early Access — free while we kick the tires
EdgarHawk

McLoughlin Karen

Director

Director
1 filing analyzed · 1 company · Latest 2024-12-13

Companies

Company Buys Sells Direction
agilon health, inc. AGL 1 0 Net buying

Activity

December 2024
2024-12-13 agilon health, inc. AGL
high
Buy
25,000 shares
$55,085
Significance 6/10

Director McLoughlin Karen bought 25,000 shares of AGL at $2.20; 3 other insiders also bought within 14 days. Stock down 83.5% from 52-week high.

McLoughlin Karen purchased 25,000 shares at $2.20, increasing her holdings by 51.9% to 73,166 shares post-transaction. This buy occurs as part of a cluster pattern in which 3 other insiders also purchased shares within the past 14 days, indicating broad insider participation at depressed price levels. The stock is trading 83.5% below its 52-week high of $339.25, though it has recovered 19.2% over the past 30 days from recent lows. Despite strong annual revenue growth of 59.4% and $1.5B in latest quarterly revenue, the company remains unprofitable with $-117.6M net income over its most recent full fiscal year, presenting a material disconnect between growth and profitability that warrants investor attention.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access